1.
The overwhelming majority (~90%) of patients with pancreatic ductal adenocarcinoma (PDAC) will be treated with systemic standard-of-care chemotherapeutic regimens at some [...]
2022 | Dissertation |
2.
A dissertation discussing the role of mesenchymal kit ligand (kitl) in the pancreas, specifically in regards to healthy tissue homeostasis, tissue architecture, and disea [...]
2025-03-21 | Dissertation |
3.
4.
As a part of the Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) precision medicine cancer trial, serial biopsies from cancer patients ar [...]
2021 | Abstract |
5.
There are increasing reports of the benefits of the adoption of mobile health (mHealth) technology such as PDAs and smartphones for health services, data collection, trea [...]
2014 | Capstone |